Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Pulmonary vein thrombi in a patient with paroxysmal atrial fibrillation.

Takeuchi H.

Int J Cardiol Heart Vasc. 2014 Oct 16;5:63-64. doi: 10.1016/j.ijcha.2014.10.006. eCollection 2014 Dec. No abstract available.

2.

JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.

Su Y, Yu QH, Wang XY, Yu LP, Wang ZF, Cao YC, Li JD.

BMC Cancer. 2017 Jul 11;17(1):477. doi: 10.1186/s12885-017-3473-4.

3.

MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress.

Bleuyard JY, Fournier M, Nakato R, Couturier AM, Katou Y, Ralf C, Hester SS, Dominguez D, Rhodes D, Humphrey TC, Shirahige K, Esashi F.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7671-7676. doi: 10.1073/pnas.1620208114. Epub 2017 Jul 3.

4.

MYC-Master Regulator of the Cancer Epigenome and Transcriptome.

Poole CJ, van Riggelen J.

Genes (Basel). 2017 May 13;8(5). pii: E142. doi: 10.3390/genes8050142. Review.

5.

2i Maintains a Naive Ground State in ESCs through Two Distinct Epigenetic Mechanisms.

Sim YJ, Kim MS, Nayfeh A, Yun YJ, Kim SJ, Park KT, Kim CH, Kim KS.

Stem Cell Reports. 2017 May 9;8(5):1312-1328. doi: 10.1016/j.stemcr.2017.04.001. Epub 2017 Apr 27.

6.

Shaping the cellular landscape with Set2/SETD2 methylation.

McDaniel SL, Strahl BD.

Cell Mol Life Sci. 2017 Sep;74(18):3317-3334. doi: 10.1007/s00018-017-2517-x. Epub 2017 Apr 6. Review.

PMID:
28386724
7.

Highly selective inhibition of histone demethylases by de novo macrocyclic peptides.

Kawamura A, Münzel M, Kojima T, Yapp C, Bhushan B, Goto Y, Tumber A, Katoh T, King ON, Passioura T, Walport LJ, Hatch SB, Madden S, Müller S, Brennan PE, Chowdhury R, Hopkinson RJ, Suga H, Schofield CJ.

Nat Commun. 2017 Apr 6;8:14773. doi: 10.1038/ncomms14773.

8.

Stress and the Emerging Roles of Chromatin Remodeling in Signal Integration and Stable Transmission of Reversible Phenotypes.

Weaver IC, Korgan AC, Lee K, Wheeler RV, Hundert AS, Goguen D.

Front Behav Neurosci. 2017 Mar 15;11:41. doi: 10.3389/fnbeh.2017.00041. eCollection 2017. Review.

9.

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG, Evans CP.

Cancers (Basel). 2017 Jan 16;9(1). pii: E9. doi: 10.3390/cancers9010009. Review.

10.

JMJD-5/KDM8 regulates H3K36me2 and is required for late steps of homologous recombination and genome integrity.

Amendola PG, Zaghet N, Ramalho JJ, Vilstrup Johansen J, Boxem M, Salcini AE.

PLoS Genet. 2017 Feb 16;13(2):e1006632. doi: 10.1371/journal.pgen.1006632. eCollection 2017 Feb.

11.

Epigenetic control of cancer by neuropeptides.

Galoian K, Patel P.

Biomed Rep. 2017 Jan;6(1):3-7. doi: 10.3892/br.2016.804. Epub 2016 Nov 8.

12.

Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation.

Tomaz RA, Harman JL, Karimlou D, Weavers L, Fritsch L, Bou-Kheir T, Bell E, Del Valle Torres I, Niakan KK, Fisher C, Joshi O, Stunnenberg HG, Curry E, Ait-Si-Ali S, Jørgensen HF, Azuara V.

Development. 2017 Feb 15;144(4):567-579. doi: 10.1242/dev.142489. Epub 2017 Jan 13.

13.

KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.

Castellini L, Moon EJ, Razorenova OV, Krieg AJ, von Eyben R, Giaccia AJ.

Nucleic Acids Res. 2017 Apr 20;45(7):3674-3692. doi: 10.1093/nar/gkw1281.

14.

Histone H3K9 Demethylase JMJD2B Activates Adipogenesis by Regulating H3K9 Methylation on PPARγ and C/EBPα during Adipogenesis.

Jang MK, Kim JH, Jung MH.

PLoS One. 2017 Jan 6;12(1):e0168185. doi: 10.1371/journal.pone.0168185. eCollection 2017.

15.

Quantitative Analysis and Discovery of Lysine and Arginine Modifications.

Galligan JJ, Kingsley PJ, Wauchope OR, Mitchener MM, Camarillo JM, Wepy JA, Harris PS, Fritz KS, Marnett LJ.

Anal Chem. 2017 Jan 17;89(2):1299-1306. doi: 10.1021/acs.analchem.6b04105. Epub 2016 Dec 30.

16.

The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy.

Thienpont B, Aronsen JM, Robinson EL, Okkenhaug H, Loche E, Ferrini A, Brien P, Alkass K, Tomasso A, Agrawal A, Bergmann O, Sjaastad I, Reik W, Roderick HL.

J Clin Invest. 2017 Jan 3;127(1):335-348. doi: 10.1172/JCI88353. Epub 2016 Nov 28.

17.

The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.

Wilson C, Qiu L, Hong Y, Karnik T, Tadros G, Mau B, Ma T, Mu Y, New J, Louie RJ, Gunewardena S, Godwin AK, Tawfik OW, Chien J, Roby KF, Krieg AJ.

Oncogene. 2017 May 4;36(18):2565-2576. doi: 10.1038/onc.2016.412. Epub 2016 Nov 21.

18.

Reader domain specificity and lysine demethylase-4 family function.

Su Z, Wang F, Lee JH, Stephens KE, Papazyan R, Voronina E, Krautkramer KA, Raman A, Thorpe JJ, Boersma MD, Kuznetsov VI, Miller MD, Taverna SD, Phillips GN Jr, Denu JM.

Nat Commun. 2016 Nov 14;7:13387. doi: 10.1038/ncomms13387.

19.

Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives.

Bishop T, Ratcliffe PJ.

Hypoxia (Auckl). 2014 Dec 5;2:197-213. eCollection 2014. Review.

20.

H3K36 methylation state and associated silencing mechanisms.

Suzuki S, Murakami Y, Takahata S.

Transcription. 2017 Jan;8(1):26-31. doi: 10.1080/21541264.2016.1246076. Epub 2016 Oct 10.

PMID:
27723431

Supplemental Content

Support Center